Adam Koppel, EVP, Strategy and Business Development at BIOGEN INC. (BIIB), sold 102 shares at $275.00 ($28K) on 2016-04-06, disclosed to the SEC on 2016-04-07.
Scheduled sale ($28k) by EVP, Strategy and Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| SWTX | SELL | 2021-03-11 | $103.7M | — | Filing → |
| DRNA | SELL | 2020-12-14 | $23.4M | — | Filing → |
| CERE | BUY | 2020-11-12 | $6.8M | — | Filing → |